Cognition Therapeutics Inc

Ownership Transactions Reported by 17 Insiders

Symbol
CGTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2403 Sidney Street, Suite 261, Pittsburgh, Pennsylvania

Insiders trading volume in the past year

Cognition Therapeutics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Aaron G.L. Fletcher Director, 10%+ Owner $11.7 M Jun 7, 2024
Leslie W. Kreis Director, 10%+ Owner $11.7 M Jun 7, 2024
Ogden CAP Associates, LLC 10%+ Owner $2.32 M Oct 13, 2021
BIOS Memory SPV I, LP 10%+ Owner $1.5 M Oct 13, 2021
Bios Clinical Opportunity Fund, LP Director, 10%+ Owner $525 K Nov 8, 2023
Lisa Ricciardi CEO & President, Director $510 K +$9.98 K +2% Mar 14, 2024
Mark H. Breedlove Director $433 K Oct 13, 2021
Anthony Caggiano Chief Medical Officer $324 K Feb 15, 2024
John Brendan Doyle Chief Financial Officer $236 K May 1, 2024
Peggy Wallace Director $102 K Jun 7, 2024
Ellen B. Richstone Director $47.8 K Jun 7, 2024
Jack A. Khattar Director $28.3 K Jun 7, 2024
Brett P. Monia Director $28.3 K Jun 7, 2024
Golden Seeds Cognition Therapeutics LLC 10%+ Owner Sep 27, 2022
James O'Brien Chief Financial Officer Mar 23, 2022
Andrew J. Einhorn Interim CFO Aug 12, 2022
BP Directors, LP Affiliate of director Jan 31, 2022

Recent Insider Transactions by Companies or Individuals for Cognition Therapeutics Inc

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership